LOGIN  |  REGISTER
Assertio
C4 Therapeutics

Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference

September 04, 2024 | Last Trade: US$2.00 0.19 -8.47

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 04, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions in rehabilitation, and recovery, announced that Larry Jasinski, Chief Executive Officer, will present and host one-on-one meetings with investors at the H.C. Wainwright 26th Annual Global Investment Conference on September 9-11, 2024 at the Lotte New York Palace Hotel in New York City.

The recorded webcast of the Lifeward management presentation will be available starting at 1:30 pm EDT on September 11, 2024 through the Investors section of the Lifeward website or by clicking here. The archived webcast of the presentation will remain accessible for 90 days following the event.

This conference appearance offers an opportunity for Lifeward to showcase its pioneering efforts to deliver breakthrough technology to advance the standard of care for people with physical limitations or disabilities. Lifeward’s portfolio of proven solutions features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES bike, and the ReStore Exo-Suit. These groundbreaking solutions span the continuum of care, delivering functional and health benefits in clinical settings as well as in the home and community.

To learn more about the Lifeward mission and product portfolio, please visit GoLifeward.com.

About Lifeward

Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit.

Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward portfolio, please visit GoLifeward.com.

ReWalk®, ReStore® and Alter G® are registered trademarks of ReWalk Robotics Ltd. (DBA Lifeward) and/or its affiliates.

Lifeward Media Relations Contact:
Kathleen O’Donnell
Vice President, Marketing & New Business Development
E: This email address is being protected from spambots. You need JavaScript enabled to view it.

Lifeward Investor Contact:
Mike Lawless
Chief Financial Officer
E: This email address is being protected from spambots. You need JavaScript enabled to view it.

Terns Pharmaceuticals

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page